Karrie Du

470 total citations
5 papers, 48 citations indexed

About

Karrie Du is a scholar working on Oncology, Biomedical Engineering and Hematology. According to data from OpenAlex, Karrie Du has authored 5 papers receiving a total of 48 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 2 papers in Biomedical Engineering and 1 paper in Hematology. Recurrent topics in Karrie Du's work include CAR-T cell therapy research (4 papers), Immune Cell Function and Interaction (1 paper) and Nanowire Synthesis and Applications (1 paper). Karrie Du is often cited by papers focused on CAR-T cell therapy research (4 papers), Immune Cell Function and Interaction (1 paper) and Nanowire Synthesis and Applications (1 paper). Karrie Du collaborates with scholars based in United States and Australia. Karrie Du's co-authors include Shin‐Young Park, Moonsoo M. Jin, Jiayun Lu, Li Chai, Carl R. Walkley, Yan Sun, Hongbo R. Luo, Leslie E. Silberstein, César Nombela‐Arrieta and Janusz Puc and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Experimental Hematology.

In The Last Decade

Karrie Du

5 papers receiving 47 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karrie Du United States	5	28	14	10	9	9	5	48
Jaap A. van Doesum Netherlands	6	46 1.6×	10 0.7×	10 1.0×	6 0.7×	8 0.9×	11	63
Isabella Y. Kong Australia	5	24 0.9×	20 1.4×	24 2.4×	23 2.6×	6 0.7×	10	62
Alexander J. Li China	2	20 0.7×	14 1.0×	27 2.7×	3 0.3×	7 0.8×	2	55
Alexander Desuki Germany	6	35 1.3×	25 1.8×	36 3.6×	6 0.7×	10 1.1×	16	69
Michela Mirenda Italy	4	16 0.6×	31 2.2×	25 2.5×	10 1.1×	5 0.6×	10	59
Pere Barba Spain	4	59 2.1×	11 0.8×	13 1.3×	14 1.6×	10 1.1×	17	67
Neeharika Kothapalli United States	4	22 0.8×	37 2.6×	44 4.4×	11 1.2×	9 1.0×	8	88
Katayoon Kasaian Canada	2	25 0.9×	7 0.5×	29 2.9×	15 1.7×	5 0.6×	2	70
Erica Hong United States	3	38 1.4×	7 0.5×	13 1.3×	4 0.4×	4 0.4×	5	53
Ivana William United States	4	34 1.2×	39 2.8×	20 2.0×	5 0.6×	5 0.6×	9	76

Countries citing papers authored by Karrie Du

Since Specialization

Citations

This map shows the geographic impact of Karrie Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karrie Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karrie Du more than expected).

Fields of papers citing papers by Karrie Du

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karrie Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karrie Du. The network helps show where Karrie Du may publish in the future.

Co-authorship network of co-authors of Karrie Du

This figure shows the co-authorship network connecting the top 25 collaborators of Karrie Du. A scholar is included among the top collaborators of Karrie Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karrie Du. Karrie Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Srour, Samer A., Victoria Villaflor, Jochen H. Lorch, et al.. (2024). Safety and efficacy of AIC100 chimeric antigen receptor (CAR) T-cell therapy in patients with advanced thyroid cancers: Results from the phase 1 study.. Journal of Clinical Oncology. 42(16_suppl). 6112–6112. 5 indexed citations

2.

Yang, Yanping, Janusz Puc, Yogindra Vedvyas, et al.. (2023). Inducible expression of interleukin-12 augments the efficacy of affinity-tuned chimeric antigen receptors in murine solid tumor models. Nature Communications. 14(1). 2068–2068. 18 indexed citations

3.

Srour, Samer A., Maria E. Cabanillas, Sonal Gupta, et al.. (2023). Safety and early efficacy results of phase 1 study of affinity tuned and trackable AIC100 CAR T cells in ICAM-1 positive relapsed and/or refractory advanced poorly differentiated and anaplastic thyroid cancers.. Journal of Clinical Oncology. 41(16_suppl). 6095–6095. 5 indexed citations

4.

Hofe, Eric von, Yen‐Michael S. Hsu, Thomas J. Fahey, et al.. (2022). Phase I study of AIC100 in relapsed and/or refractory advanced thyroid cancer and anaplastic thyroid cancer.. Journal of Clinical Oncology. 40(16_suppl). 6093–6093. 5 indexed citations

5.

Lu, Jiayun, Yan Sun, César Nombela‐Arrieta, et al.. (2011). Fak depletion in both hematopoietic and nonhematopoietic niche cells leads to hematopoietic stem cell expansion. Experimental Hematology. 40(4). 307–317.e3. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact